Location History:
- Seoul, KR (2003)
- Mapo-ku, Seoul, KR (2007)
Company Filing History:
2 out of 832,843 Years Active: 2003-2007
Title: Keon Hyoung Lee: Innovator in Controlled Drug Delivery Systems
Introduction
Keon Hyoung Lee is a notable inventor based in Mapo-gu, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to biodegradable polymers. With a total of two patents to his name, Lee's work focuses on enhancing the efficiency and effectiveness of drug release mechanisms.
Latest Patents
Lee's latest patents revolve around a controlled drug delivery system that utilizes the conjugation of drugs to biodegradable polyester. This invention describes a molecular sustained controlled release system that is constructed by covalently bonding the molecules to be released with biodegradable polyester polymers. The system can be formulated into various forms, including microspheres, nanoparticles, or films. The molecular release rate can be regulated to align with the chemical degradation rate of the biodegradable polyester, achieving a near zero-order kinetics profile without a burst effect. Additionally, this system allows for high loading efficiency of hydrophilic drugs, making it a significant advancement in drug delivery technology.
Career Highlights
Throughout his career, Keon Hyoung Lee has focused on developing innovative solutions in the pharmaceutical field. His work has been recognized for its potential to improve patient outcomes through more effective drug delivery methods. Lee's expertise in polymer chemistry and drug formulation has positioned him as a key figure in this area of research.
Collaborations
Lee has collaborated with notable colleagues, including Jong Eun Oh and Tae Gwan Park. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Keon Hyoung Lee's contributions to controlled drug delivery systems highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing drug delivery technologies, which can significantly impact patient care and treatment efficacy.